Legal Basis and Women’s Safety at Issue

"Establishing a Safe System of Use and Management After Authorization"

As the government is moving forward with the introduction of abortion medication, controversy has arisen in the National Assembly over the potential conflict with the current legal framework.


Jeong Eun-kyung, Minister of Health and Welfare, is responding to lawmakers' questions at the Health and Welfare Committee's audit held at the National Assembly on the 7th. Photo by Yonhap News

Jeong Eun-kyung, Minister of Health and Welfare, is responding to lawmakers' questions at the Health and Welfare Committee's audit held at the National Assembly on the 7th. Photo by Yonhap News

View original image

Jung Eun-kyeong, Minister of Health and Welfare, at the National Assembly’s Health and Welfare Committee audit on October 7, responded to Assemblywoman Cho Bae-sook of the People Power Party, who pointed out that the introduction of abortion medication contradicts the current legal system. Minister Jung said, "As the Constitutional Court has determined, I agree that we need to balance and harmonize women's right to self-determination and the fetus' right to life. This should be addressed by amending the law."


During the session, Assemblywoman Cho highlighted that seven years have passed since the Constitutional Court's 2019 ruling of nonconformity regarding abortion laws, yet no relevant legislation has been updated. She pointed out that although the current Mother and Child Health Act makes exceptions to allow abortion, these exceptions are presupposed on surgical procedures, meaning there is no clear legal basis for the use of medication.


Assemblywoman Cho particularly argued that introducing abortion medication through administrative measures without amending the Criminal Act, the Mother and Child Health Act, and the Pharmaceutical Affairs Act risks infringing on the authority of the legislature. She emphasized, "All legal issues must be resolved through statutory reform before introducing medication," and stressed the need to amend both the Criminal Act and the Mother and Child Health Act. Additionally, she asserted that before introducing abortion medication used overseas into Korea, safety assessments—including bridging studies that consider the unique characteristics of Korean women—must be conducted.


Minister Jung responded, "In accordance with the Constitutional Court’s intent, we must harmoniously guarantee both women's right to self-determination and the fetus' right to life. This should be completed through legislative amendment." She also agreed on the need for simultaneous amendments to the Criminal Act and the Mother and Child Health Act. However, Minister Jung explained, "The authorization and safety assessment of abortion medications fall within the jurisdiction of the Ministry of Food and Drug Safety. The necessity of bridging studies must also be determined by the MFDS."


The government cited several reasons for reviewing the introduction of abortion medication: the illegal distribution of abortion drugs, the prevalence of counterfeit drugs, and gaps in the management of misuse and side effects. Minister Jung stated, "After authorization, it is necessary to establish a safe system for use and management, based on the approval details," and added, "We will work with the medical community to build a related management system." She further commented, "Regarding amendments to the Criminal Act and the Mother and Child Health Act, the government will actively participate in discussions at the National Assembly, express our opinions, and provide supporting materials."



It was also mentioned that the use of abortion medication may be more beneficial for women's health compared to surgical abortions. Minister Jung stated, "According to statistics from the medical community and other countries where abortion medication has been introduced, the use of medication in early pregnancy is significantly better for women's health or results in fewer side effects than surgical procedures. Judgement must be made considering practical issues related to women's health."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing